277 (Januvia 100 mg)

Generic Name: sitagliptin

Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc..

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 277

Januvia

Generic Name: sitagliptin
Imprint: 277
Strength: 100 mg
Color: Brown
Size: 10.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Dipeptidyl peptidase 4 inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Merck & Company Inc.
Inactive Ingredients: calcium phosphate dibasic anhydrous, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00006-0277 (Discontinued)	Merck
54569-5925	A-S Medication Solutions, LLC (repackager)
54868-5840	Physicians Total Care Inc. (repackager)
35356-0103 (Discontinued)	Lake Erie Medical and Surgical Supply (repackager)